Fol. Biol. 2020, 66, 17-23
https://doi.org/10.14712/fb2020066010017
Anti-CD38 Therapy with Daratumumab for Relapsed/Refractory CD20-Negative Diffuse Large B-Cell Lymphoma
Individual author index pages
Other articles of these authors
-
PD-1, PD-L1 and PD-L2 Expression in Mantle Cell Lymphoma and Healthy Population
J. Karolova, M. Radek, K. Helman, M. Spacek, Marek Trněný, Pavel Klener
2020, Vol. 66, Issue 4, pp. 117-122 -
Molecularly-Targeted and Biological Anti-Cancer Therapy
P. Klener, Jr., Pavel Klener
2012, Vol. 58, Issue 1, pp. 1-6 -
Hepcidin Expression in the Liver of Mice with Implanted Tumour Reacts to Iron Deficiency, Inflammation and Erythropoietin Administration
Martin Vokurka, J. Krijt, J. Vávrová, E. Nečas
2011, Vol. 57, Issue 6, pp. 248-254 -
Immune Characterization of the Lewis Rats Inoculated with K2 Sarcoma Cell Line and Newly Derived R5-28 Malignant Cells
Alena Morávková, O. Málek, E. Pokorná, J. Strnádel, J. Hradecký, V. Horák
2005, Vol. 51, Issue 6, pp. 159-165
